Eric Weinberg Discusses His Recent Work, "Blood On Their Hands" (September 28th)
www.thehealthcarepolicypodcast.com
Listen Now Mr. Eric Weinberg is co-author with College of New Jersey Journalism Professor, Donna Shaw, of the recently published work, Blood On Their Hands, How Greedy Companies, Inept Bureaucracy, and Bad Science Killed Thousands of Hemophiliacs (Rutgers University Press). The book details how beginning in the late 1970s through the mid-1980s tens of thousands of hemophiliacs in the US (and tens of thousands more around the world) became infected with HIV via the use of life-saving plasma-based blood clotting medicines. Manufactures knew plasma-based products transmitted disease, for example, it was well known clotting medicines had infected countless hemophiliacs with hepatitis. Nevertheless, neither did they cleanse or purify their blood clotting products, technology that was also well known, nor warn patients of adverse side effects. Federal regulators, similarly, did nothing. As a result, by the late 1980s the mean life span of a hemophiliac declined by over fifteen years. While (civil) financial settlements were reached with approximately 6,000 victims or their families and the Congress passed in 1998 legislation, the Ricky Ray Hemophilia Relief Act, that provided additional compensation, the Justice Department chose not to criminally prosecute anyone.
Eric Weinberg Discusses His Recent Work, "Blood On Their Hands" (September 28th)
Eric Weinberg Discusses His Recent Work…
Eric Weinberg Discusses His Recent Work, "Blood On Their Hands" (September 28th)
Listen Now Mr. Eric Weinberg is co-author with College of New Jersey Journalism Professor, Donna Shaw, of the recently published work, Blood On Their Hands, How Greedy Companies, Inept Bureaucracy, and Bad Science Killed Thousands of Hemophiliacs (Rutgers University Press). The book details how beginning in the late 1970s through the mid-1980s tens of thousands of hemophiliacs in the US (and tens of thousands more around the world) became infected with HIV via the use of life-saving plasma-based blood clotting medicines. Manufactures knew plasma-based products transmitted disease, for example, it was well known clotting medicines had infected countless hemophiliacs with hepatitis. Nevertheless, neither did they cleanse or purify their blood clotting products, technology that was also well known, nor warn patients of adverse side effects. Federal regulators, similarly, did nothing. As a result, by the late 1980s the mean life span of a hemophiliac declined by over fifteen years. While (civil) financial settlements were reached with approximately 6,000 victims or their families and the Congress passed in 1998 legislation, the Ricky Ray Hemophilia Relief Act, that provided additional compensation, the Justice Department chose not to criminally prosecute anyone.